KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

NovoCure (NVCR) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to -$37.3 million.

  • NovoCure's Income from Continuing Operations fell 2191.69% to -$37.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$177.6 million, marking a year-over-year decrease of 1860.41%. This contributed to the annual value of -$168.6 million for FY2024, which is 1855.46% up from last year.
  • According to the latest figures from Q3 2025, NovoCure's Income from Continuing Operations is -$37.3 million, which was down 2191.69% from -$40.1 million recorded in Q2 2025.
  • NovoCure's Income from Continuing Operations' 5-year high stood at -$4.1 million during Q1 2021, with a 5-year trough of -$65.9 million in Q4 2024.
  • Its 5-year average for Income from Continuing Operations is -$33.6 million, with a median of -$34.3 million in 2025.
  • In the last 5 years, NovoCure's Income from Continuing Operations tumbled by 104183.34% in 2023 and then surged by 4187.36% in 2024.
  • Over the past 5 years, NovoCure's Income from Continuing Operations (Quarter) stood at -$26.5 million in 2021, then tumbled by 40.99% to -$37.3 million in 2022, then decreased by 26.21% to -$47.1 million in 2023, then plummeted by 40.02% to -$65.9 million in 2024, then soared by 43.46% to -$37.3 million in 2025.
  • Its Income from Continuing Operations stands at -$37.3 million for Q3 2025, versus -$40.1 million for Q2 2025 and -$34.3 million for Q1 2025.